profit from every $100 of sales.
$0$100
Scienture Holdings
$2.90-3.65% today
-82.7% in 1 year
1-year low $2.771-year high $16.81
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Scienture Holdings sold, what it kept, and what it did with the cash.
Sales went from $10.3 million in 2022 to $431,609 in 2025, with -$41.5 million of profit last year.
SalesProfit
Scienture Holdings vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Scienture Holdings | No profit yet | ||
 JD Health International | 20.5× · Fair price | ||
 Tsuruha Holdings | 26.6× · Fair price | ||
 MatsukiyoCocokara & | 20.1× · Fair price | ||
 Yifeng Pharmacy Chain | 18.4× · Fair price |
AI analysis
An AI analyst reads Scienture Holdings's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 10 | 1 | 0 | 0 | |
| 6 | 0 | 0 | 0 | |
| -2 | -4 | -15 | -16 | |
| -2 | -6 | -17 | -39 | |
| -3 | -18 | 9 | -42 | |
| -6.15 | -23.35 | 2.48 | -2.70 | |
| 53.8% | 3.6% | 4.4% | 76.8% | |
| -19.9% | -322.4% | -10,758.7% | -3,763.8% | |
| -33.9% | -1,308.3% | 6,634.7% | -9,618.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 4 | 13 | 105 | 84 |
| Cash | 1 | 0 | 0 | 7 |
| Total debt | 2 | 0 | 4 | 0 |
| Total liabilities | 3 | 12 | 26 | 14 |
| 1 | 1 | 79 | 70 | |
| 1 | 2 | 4 | 15 | |
| -69.6% | -771.2% | -16.7% | -44.4% | |
| -455.0% | -3,290.0% | 11.5% | -59.2% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -2 | -2 | -14 | -13 | |
| 0 | – | 0 | – | |
| -2 | -2 | -14 | -13 | |
| Dividends paid | – | 0 | 15 | 0 |
| – | – | – | – | |
| 0 | 0 | 0 | 2 |
Valuation
- –
- –
- –
- 0.2×
- 11.0×
- –
- –
- -280.9%
- -871.5%
- 0.0%
Profitability
- 76.8%
- -3,763.8%
- -9,618.0%
- -9,020.2%
- -45.5%
- -231.2%
- -236.0%
- -49.3%
- -53.4%
- 453,250.4%
Growth
- −65.2%
- –
- −93,633.0%
- –
- +200.6%
Financial health
- -0.2×
- 0.00
- 0.0%
- -9.7×
- 2.89
- 2.82
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 7%of 963
Bottom 1%of 908
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 11, 2026 | -0.08 | -0.23 | +65.2% |
| Mar 24, 2026 | -1.76 | -0.22 | −700.0% |
| Nov 12, 2025 | -0.19 | – | – |
| Aug 12, 2025 | -0.48 | – | – |
| May 12, 2025 | -0.33 | – | – |
| Mar 26, 2025 | -0.82 | – | – |
| Nov 6, 2024 | -1.34 | -0.15 | −793.3% |
| Aug 9, 2024 | -1.04 | -0.15 | −593.3% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/6Passes 1 of 6. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
78Pass
Philip Fisher
52No pass
Peter Lynch
–Not enough data
Joel Greenblatt
0No pass
Charlie Munger
47No pass
Terry Smith
43No pass
Questions about Scienture Holdings
Is Scienture Holdings a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 6 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Scienture Holdings AI analysis
What does Scienture Holdings do?
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. It is in Pharmaceutical Retailers.
Does Scienture Holdings pay a dividend?
No. Scienture Holdings does not pay a dividend at the moment.
Is Scienture Holdings stock halal?
No. Scienture Holdings does not pass our halal screen: its cash and confirmed interest-bearing investments are 140% of its market value, at or above the 33% limit. How we check
How has Scienture Holdings stock done over the past year?
Down 82.7% over the past twelve months, to $2.90. It traded between $2.77 and $16.81 and is 82.7% below its high.
Who are Scienture Holdings's competitors?
The largest listed companies in the same industry are JD Health International, Tsuruha Holdings, MatsukiyoCocokara & and Yifeng Pharmacy Chain. The peers table on this page compares their profit, growth and price with Scienture Holdings's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.